Foamix Pharmaceuticals (FOMX) Priced

Israeli biotech developing topical foam treatments for moderate-to-severe acne.

Health Care - Biotechnology

IPO Performance
Latest Trade $10.24 0.00 (0.0%)
First Day Return 3.7%
Return from IPO 70.7%
 
Foamix Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 08/13/2014
Offer Price $6.00
Price Range $10.00 - $12.00
Offer Shares (mm) 6.7
Deal Size ($mm) 40
 
IPO Data
IPO Date 09/17/2014
Offer Price $6.00
Price Range $10.00 - $12.00
Offer Shares (mm) 6.7
Deal Size ($mm) $40
 
Underwriters
more
Business Overview
Israeli biotech developing topical foam treatments for moderate-to-severe acne.
Israeli biotech developing topical foam treatments for moderate-to-severe acne.
more
Company Data
Headquarters Rehovot, , Israel
Founded 2003
Employees 24
Website www.foamix.co.il
 

Performance vs. IPO Index (IPOUSA)